Spinal implant aims to restore walking in paralysis patients

NCT ID NCT07234903

Recruiting now Disease control Sponsor: Ecole Polytechnique Fédérale de Lausanne Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study is testing a device called ARC-IM Therapy, which delivers electrical impulses to the lower spinal cord, to see if it can help people with spinal cord injury regain the ability to walk. The trial will include 12 adults with recent or long-term injuries. The main goal is to check safety, but researchers will also measure any improvements in walking and nerve function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ARC-IM Lumbar System (epidural electrical stimulation device)
What this could lead to: If it works, this could point toward a way to help people with spinal cord injury regain some walking ability.
What could go wrong: This is a very early, small study (12 people) focused on safety. It may not lead to a proven treatment, and there are risks from the implantation procedure and stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SPINAL CORD INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC SPINAL CORD INJURY SCI SCI - SPINAL CORD INJURY SPINAL CORD INJURY SPINAL CORD INJURY(SCI) SUBACUTE SPINAL CORD INJURY

Contacts and locations

Locations

Centre Hospitalier Universitaire Vaudois (CHUV)
RECRUITING

Lausanne, Canton of Vaud, 1011, Switzerland
Schweizer Paraplegiker-Zentrum (SPZ)
NOT_YET_RECRUITING

Nottwil, Canton of Lucerne, 6207, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.